Syncom Formulations (India) Limited Peer Comparison
SYNCOMF · Healthcare · Current price ₹22.01
Peers tracked
11
Syncom Formulations (India) Limited P/E
27.2x
Sector
Healthcare
Syncom Formulations (India) Limited vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,758.8 | 36.9x | 4,22,273 |
| Divi's Laboratories Limited | ₹9,144.5 | 85.4x | 2,44,762 |
| Torrent Pharmaceuticals Limited | ₹4,558.9 | 86.9x | 1,73,442 |
| Zydus Lifesciences Limited | ₹1,123 | 24.3x | 1,12,149 |
| Laurus Labs Limited | ₹2,060.1 | 95.9x | 1,11,250 |
| Cipla Limited | ₹1,325.1 | 33.2x | 1,07,043 |
| Dr. Reddy's Laboratories Limited | ₹1,233 | 29.9x | 1,02,815 |
| Aurobindo Pharma Limited | ₹1,666.9 | 25.9x | 95,513 |
| Mankind Pharma Limited | ₹2,275.5 | 44.9x | 93,968 |
| Lupin Limited | ₹1,961.6 | 17.1x | 89,437 |
| Syncom Formulations (India) Limited | ₹21.95 | 17.6x | 2,060 |
Syncom Formulations (India) Limited versus its peers
Syncom Formulations (India) Limited operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 27.2x may be cheap in one industry and expensive in another.
More on Syncom Formulations (India) Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.